Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma-Reference-Cited by-同舟云学术

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

Published:2005-06 Issue:5 Volume:129 Page:631-643
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kroger Nicolaus,Shaw Bronwen,Iacobelli Simona,Zabelina Tatjana,Peggs Karl,Shimoni Avichai,Nagler Arnon,Binder Thomas,Eiermann Thomas,Madrigal Alejandro,Schwerdtfeger Rainer,Kiehl Michael,Sayer Herbert Gottfried,Beyer Jorg,Bornhauser Martin,Ayuk Francis,Zander Axel Rolf,Marks David I.,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05513.x/fullpdf

Reference45 articles.

1. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect

2. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma

3. Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants

4. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

5. CD34+ -enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Letermovir for CMV Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.;Transplantation and Cellular Therapy;2024-09

2. The evolution of immune dysfunction in multiple myeloma;European Journal of Haematology;2022-09-19

3. Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma;International Journal of Molecular Sciences;2022-04-25

4. Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2022-02-26

5. Harnessing natural killer cells for the treatment of multiple myeloma;Seminars in Oncology;2022-02